ProKidney Corp.

News & Events

Press Releases

In The Media

1. ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

   GlobeNewswire OCT 29, 2025 7:30 AM EDT
   WINSTON-SALEM, N.C., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (ȁ...
   Read Article

2. ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025

   GlobeNewswire OCT 20, 2025 7:30 AM EDT
   WINSTON-SALEM, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (ȁ...
   Read Article

3. ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

   GlobeNewswire AUG 27, 2025 7:30 AM EDT
   WINSTON-SALEM, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (ȁ...
   Read Article

4. ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

   GlobeNewswire AUG 12, 2025 4:01 PM EDT
   FDA confirmed at a July 2025 Type B meeting and in the subsequent meeting minutes that eGFR slope...
   Read Article

5. ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

   GlobeNewswire JUL 15, 2025 7:30 AM EDT
   FDA confirmed that eGFR slope is an acceptable surrogate endpoint for accelerated approval of ril...
   Read Article

6. ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

   GlobeNewswire JUL 9, 2025 7:30 AM EDT
   WINSTON-SALEM, N.C., July 09, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (ȁ...
   Read Article

7. ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

   GlobeNewswire JUL 8, 2025 7:00 AM EDT
   Full results from REGEN-007 are being held and will be submitted to the American Society of Nephr...
   Read Article

8. ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware

   GlobeNewswire JUL 1, 2025 12:43 PM EDT
   WINSTON-SALEM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (ȁ...
   Read Article

9. ProKidney Reports First Quarter 2025 Financial Results and Business Highlights

   GlobeNewswire MAY 12, 2025 4:15 PM EDT
   Full data from Group 1 in the Phase 2 REGEN-007 study expected in Q2 2025 FDA previously ...
   Read Article

10. ProKidney Reports Full Year 2024 Financial Results and Business Highlights

    GlobeNewswire MAR 17, 2025 7:30 AM EDT
    Significant progress was made in 2024, including refining the Phase 3 program to accelerate rilpa...
    Read Article